742872
Last Update Posted: 2013-04-09
Recruiting has ended
All Genders accepted | 18 Years-75 Years |
41 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
The purpose of this study is to determine whether Mosapride, an agent which acts on serotonin receptors in the gastrointestinal tract, is effective in the treatment of constipation-predominant irritable bowel syndrome (C-IBS).
Eligibility
Relevant conditions:
Constipation-Predominant Irritable Bowel Syndrome
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov